Condition: Locally Advanced Rectal Cancer · Older People · Sponsor: Jules Bordet Institute
The SHAPERS study is a multicentre, open-label, randomised, pragmatic clinical trial, comparing standard-of-care neoadjuvant treatment options for older (i.e., ≥70 years) subjects with high-risk stage II and stage III rectal cancer.
This description comes directly from the study's public registry record.
Sophie Lepannetier, phD · +32 (0)2 541 34 56 · ctsu.shapers@hubruxelles.be
Ikram El Idrissi · +32 (0)2 541 30 81 · ctsu.shapers@hubruxelles.be
Always discuss trial participation with your own doctor first.
| ZAS Antwerpen | Antwerp, Antwerpen, Belgium | Recruiting |
| UZA Antwerpen | Edegem, Antwerpen, Belgium | Recruiting |
| AZ Turnhout | Turnhout, Antwerpen, Belgium | Recruiting |
| Institut Jules Bordet | Anderlecht, Brussels Capital, Belgium | Recruiting |
| Chirec Delta | Auderghem, Brussels Capital, Belgium | Recruiting |
| CHU Saint-Pierre | Brussels, Brussels Capital, Belgium | Recruiting |
| CHU Brugmann | Brussels, Brussels Capital, Belgium | Recruiting |
| UZ Gent | Ghent, East Flanders, Belgium | Recruiting |
| AZ Nikolaas | Sint-Niklaas, East Flanders, Belgium | Recruiting |
| Hôpital de Jolimont | Haine-Saint-Paul, Hainaut, Belgium | Recruiting |
| Epicura | Hornu, Hainaut, Belgium | Recruiting |
| CHU Ambroise Pare | Mons, Hainaut, Belgium | Not Yet Recruiting |
+ 7 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.